Baidu
map

J Natl Cancer I:癌症存活者战胜了病魔却战胜不了财务困难

2017-05-25 吴刚 环球医学

2017年2月,发表在《J Natl Cancer Inst》的一项由美国科学家进行的系统综述,表明了癌症存活者经历的财务困难的原因及现状。背景:随着癌症医疗成本的增加,包括高价癌症药物,美国癌症存活者中,财务困难的出现越来越多。尚没有对研究结果进行过综合。方法:研究人员使用Pubmed、Embase、Scopus和CINAHL数据库,对发表于1990~2015年描述癌症存活者遭受财务困难的文章进

2017年2月,发表在《J Natl Cancer Inst》的一项由美国科学家进行的系统综述,表明了癌症存活者经历的财务困难的原因及现状。

背景:随着癌症医疗成本的增加,包括高价癌症药物,美国癌症存活者中,财务困难的出现越来越多。尚没有对研究结果进行过综合。

方法:研究人员使用Pubmed、Embase、Scopus和CINAHL数据库,对发表于1990~2015年描述癌症存活者遭受财务困难的文章进行了系统回顾。研究人员将财务困难分为物质条件(如,花光积蓄、劳动力丧失、医疗债务、破产)、心理反应(如,痛苦或烦恼)、应对行为(如,跳过药物)。研究人员提取了结果,并进行了定性综合。

结果:鉴别出的676项研究中,45项符合入组标准并纳入到本综述中。多数研究(82%,n=37)表示,因物质条件而造成财务困难;其他表示,因心理(7%,n=3)和行为(16%,n=7)造成财务困难。每一大类内,财务困难测量都是异质性的,其流行程度随着测量使用和研究人群的不同而具有差异。每年平均劳动力丧失的范围从$380到$8236,12%~62%的存活者表示因治疗而负债,47%~49%的存活者表示正经历某种形式的财务困境,4%~45%的存活者因花费而并未遵循推荐的处方药物。

结论:虽然研究人员发现了本质上影响其流行的异质性,并强调需要坚持用定义、期限、程度来决定最佳干预目标和告知干预进展,为了预防和最小化癌症存活者财务困难的影响,但是财务困难在癌症存活者中仍然常见。

原始出处

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1950194, encodeId=a9111950194bd, content=<a href='/topic/show?id=f3b329482a' target=_blank style='color:#2F92EE;'>#ATL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2948, encryptionId=f3b329482a, topicName=ATL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sun Mar 18 01:23:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882083, encodeId=e8a718820836f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 19 07:23:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=205068, encodeId=204620506851, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Jun 01 06:24:10 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202448, encodeId=7f4d202448f9, content=涨知识,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu May 25 15:53:09 CST 2017, time=2017-05-25, status=1, ipAttribution=)]
    2018-03-18 qidongfanjian
  2. [GetPortalCommentsPageByObjectIdResponse(id=1950194, encodeId=a9111950194bd, content=<a href='/topic/show?id=f3b329482a' target=_blank style='color:#2F92EE;'>#ATL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2948, encryptionId=f3b329482a, topicName=ATL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sun Mar 18 01:23:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882083, encodeId=e8a718820836f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 19 07:23:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=205068, encodeId=204620506851, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Jun 01 06:24:10 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202448, encodeId=7f4d202448f9, content=涨知识,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu May 25 15:53:09 CST 2017, time=2017-05-25, status=1, ipAttribution=)]
    2017-08-19 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=1950194, encodeId=a9111950194bd, content=<a href='/topic/show?id=f3b329482a' target=_blank style='color:#2F92EE;'>#ATL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2948, encryptionId=f3b329482a, topicName=ATL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sun Mar 18 01:23:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882083, encodeId=e8a718820836f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 19 07:23:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=205068, encodeId=204620506851, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Jun 01 06:24:10 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202448, encodeId=7f4d202448f9, content=涨知识,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu May 25 15:53:09 CST 2017, time=2017-05-25, status=1, ipAttribution=)]
    2017-06-01 大爰

    学习并分享!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1950194, encodeId=a9111950194bd, content=<a href='/topic/show?id=f3b329482a' target=_blank style='color:#2F92EE;'>#ATL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2948, encryptionId=f3b329482a, topicName=ATL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sun Mar 18 01:23:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1882083, encodeId=e8a718820836f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sat Aug 19 07:23:00 CST 2017, time=2017-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=205068, encodeId=204620506851, content=学习并分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Thu Jun 01 06:24:10 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=202448, encodeId=7f4d202448f9, content=涨知识,值得分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu May 25 15:53:09 CST 2017, time=2017-05-25, status=1, ipAttribution=)]
    2017-05-25 1ddf0692m34(暂无匿称)

    涨知识,值得分享

    0

相关资讯

Br J Gen Pract:血小板计数高——癌症的强有力预测指标!

根据大规模的研究,高血小板计数是癌症的强大预测因子,应该紧急调查挽救生命。 在英国,40至50万人中约有2%的人血小板计数升高,称为血小板增多症

ATS2017:哪种癌症容易令患者自杀?

根据ATS 2017国际会议提出的新研究,与最常见的非皮肤癌类型相比,肺癌诊断似乎使患者自杀风险最大。

Bri J Cancer:身体哪个部位脂肪多容易诱发癌症?

科学家发现,根据英国“癌症杂志”今天发表的研究报告,腰腹部携带脂肪可能与身体质量指数(BMI)一样,都是癌症的预测指标。

Cancer Res:研究表明注射肿瘤抑制因子激活剂直达病灶,大大降低毒副作用!

科学家在“癌症研究”杂志上报道,用激活天然强大的肿瘤抑制剂的药物直接注射肿瘤可增强药物在局部及其传播地点攻击肿瘤的能力。

Brit J Cancer:身体哪个部位脂肪多容易诱发癌症?

科学家发现,根据英国“癌症杂志”今天发表的研究报告,腰腹部携带脂肪可能与身体质量指数(BMI)一样,都是癌症的预测指标。

Cell Rep:诱导肺癌复发的“根源”被曝光,彻底解决化疗耐药性问题!

非小细胞肺癌患者在接受化疗初期效果不错,但是接下来就会产生耐药性,后果致命。那么,如果医生可以及早发现病人产生耐药性,是否可以找出应对的方法来避免或者解决这一问题呢?目前,来自西南大学医学研究中心的研究人员找到答案,确定肿瘤细胞的35-基因最可能对化疗产生抵抗性。发表于《细胞》杂志上的文章指出靶向对化疗产生耐药性的肺癌新药,并可以在第一时间阻止这种耐药性的产生。

Baidu
map
Baidu
map
Baidu
map